Abstract
BackgroundIn adults, the time-to-glucose-peak at or after 30minutes during an oral glucose tolerance test (OGTT) identifies physiologically distinct groups with differences in insulin sensitivity, beta-cell function and risk for type 2 diabetes. In obese non-diabetic adolescents, we investigated if the OGTT-time-to-glucose-peak also reflects incretin and free fatty acid (FFA) responses besides insulin sensitivity and beta-cell function, measured by the clamp.
MethodsObese adolescents (n = 278) were categorized according to their OGTT-time-to-glucose-peak by Early-peak (at 30minutes) vs Late-peak (>30minutes) groups. Body composition, visceral adipose tissue, oral disposition index and OGTT-area under the curve (AUC) were examined. A subset of 102 participants had both hyperinsulinemic-euglycemic and hyperglycemic clamps to measure in vivo insulin sensitivity, insulin secretion, and beta-cell function relative to insulin sensitivity.
ResultsCompared with the Early-peak group, the Late-peak group had impaired beta-cell function relative to insulin sensitivity, lower glucose-dependent insulinotropic polypeptide-AUC, and higher FFA-AUC despite higher insulin- and C-peptide-AUC. They also had lower hepatic and peripheral insulin sensitivity despite similar percent body fat and visceral adipose tissue, and had higher prevalence of impaired glucose tolerance (all P
ConclusionsIn obese non-diabetic youth, those with a Late-peak vs an Early-peak glucose during an OGTT showed diminished beta-cell function, blunted incretin secretion, and lower insulin sensitivity of glucose and FFA metabolism. It remains to be determined if Late-peak glucose predicts the future development of type 2 diabetes in these high-risk youth.
Original language | English |
---|---|
Pages (from-to) | 18-27 |
Number of pages | 10 |
Journal | Pediatric Diabetes |
Volume | 21 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2020 |
Externally published | Yes |
Keywords
- clamp
- glucose peak
- insulin sensitivity
- obesity
- OGTT
- youth
- beta-cell function
- ORAL DISPOSITION INDEX
- TYPE-2 DIABETES RISK
- TOLERANCE TEST
- ADIPOSE-TISSUE
- AFRICAN-AMERICAN
- FASTING GLUCOSE
- ACID ELEVATION
- PREDICTS
- CURVE
- CHALLENGE